The effects of lyophilization on the stability of liposomes containing 5-FU
- PMID: 15707734
- DOI: 10.1016/j.ijpharm.2004.07.045
The effects of lyophilization on the stability of liposomes containing 5-FU
Abstract
Multilamellar liposomes containing 5-fluorouracil (5-FU) were prepared by modified lipid film hydration method and were lyophilized with or without saccharose as cryoprotectant. The effect of lyophilization on the stability of liposomes was evaluated by comparing the vesicle size, encapsulation efficiency and the drug release rate before and after lyophilization/rehydration. The process of lyophilization, without cryoprotectant, resulted in particle size increase and significant content leakage. By the addition of saccharose, the lipid bilayers become more stable and less permeable to the encapsulated drug, saccharose imparted 5-FU retention of about 80% after lyophilization/rehydration. Freeze-drying did not affect the particle size of liposomes containing saccharose as cryoprotectant. The drug release profiles of rehydrated liposomes followed Higuchi's square root model. Also, the obtained release profiles were all biphasic: a rapid initial drug release phase (burst release of the portion of the drug that leaked out of liposomes during the lyophilization) was followed by a slower, approximately constant drug release phase (zero-order kinetics).
Similar articles
-
Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.Anticancer Res. 2003 Jan-Feb;23(1A):439-42. Anticancer Res. 2003. PMID: 12680245
-
A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions.J Liposome Res. 2009;19(3):231-40. doi: 10.1080/08982100902788390. J Liposome Res. 2009. PMID: 19263267
-
Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug.Biopharm Drug Dispos. 1996 Oct;17(7):589-605. doi: 10.1002/(SICI)1099-081X(199610)17:7<589::AID-BDD976>3.0.CO;2-D. Biopharm Drug Dispos. 1996. PMID: 8894117
-
An overview of liposome lyophilization and its future potential.J Control Release. 2010 Mar 19;142(3):299-311. doi: 10.1016/j.jconrel.2009.10.024. Epub 2009 Oct 27. J Control Release. 2010. PMID: 19874861 Review.
-
Proniosomes as drug carriers.Pak J Pharm Sci. 2010 Jan;23(1):103-7. Pak J Pharm Sci. 2010. PMID: 20067875 Review.
Cited by
-
Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells.Cell Mol Bioeng. 2017;10(4):275-294. doi: 10.1007/s12195-017-0497-4. Epub 2017 Jul 20. Cell Mol Bioeng. 2017. PMID: 28804522 Free PMC article. Review.
-
Inhalational system for Etoposide liposomes: formulation development and in vitro deposition.Indian J Pharm Sci. 2011 Nov;73(6):656-62. doi: 10.4103/0250-474X.100240. Indian J Pharm Sci. 2011. PMID: 23112400 Free PMC article.
-
Preparation of Glycyrrhetinic Acid Liposomes Using Lyophilization Monophase Solution Method: Preformulation, Optimization, and In Vitro Evaluation.Nanoscale Res Lett. 2018 Oct 16;13(1):324. doi: 10.1186/s11671-018-2737-5. Nanoscale Res Lett. 2018. PMID: 30327946 Free PMC article.
-
Liposome nano-formulation with cationic polar lipid DOTAP and cholesterol as a suitable pH-responsive carrier for molecular therapeutic drug (all-trans retinoic acid) delivery to lung cancer cells.IET Nanobiotechnol. 2021 Jun;15(4):380-390. doi: 10.1049/nbt2.12028. Epub 2021 Mar 8. IET Nanobiotechnol. 2021. PMID: 34694713 Free PMC article.
-
Development and evaluation of inhalational liposomal system of budesonide for better management of asthma.Indian J Pharm Sci. 2010 Jul;72(4):442-8. doi: 10.4103/0250-474X.73916. Indian J Pharm Sci. 2010. PMID: 21218054 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources